Theravance sale to Beatrice likely at premium
The guest argued a sale of Theravance's assets to its partner Beatrice is the most likely outcome, based on a pattern of similar royalty-company acquisitions at significant premiums.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.